United States Retail Pharmacy De-identified Health Data Market to Grow with a CAGR of 7.91% through 2030
The
rising adoption of real-time prescription data sharing for care coordination
and the expanding role of retail pharmacies in value-based healthcare programs, is
expected to drive the United States Retail Pharmacy De-identified Health Data
Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “United States Retail Pharmacy De-identified Health
Data Market – By Region, Competition, Forecast & Opportunities, 2030F”,
the United States Retail Pharmacy De-identified Health Data Market was valued
at USD 2.95 Billion in
2024 and is expected to reach USD 4.66 Billion by 2030 with a CAGR of 7.91%. The
United States Retail Pharmacy De-identified Health Data Market is experiencing
expansion as healthcare stakeholders increasingly recognize the commercial and
clinical value of aggregated, anonymized datasets generated by retail
pharmacies. Large pharmacy chains serve as vital access points for patient
interactions, generating a continuous flow of data related to prescription
dispensing, over-the-counter purchases, and wellness services. When stripped of
personal identifiers, this information becomes a valuable resource for
pharmaceutical research, formulary optimization, and public health
surveillance. The rapid proliferation of electronic prescription systems and
point-of-sale health data capture has significantly enhanced the scope and
depth of available datasets. Continuous investment by retail pharmacies in
digital infrastructure is enabling more efficient extraction, curation, and
distribution of de-identified datasets to interested buyers across the
healthcare ecosystem.
A
notable market trend is the growing use of cloud-based health data exchange
platforms that allow authorized stakeholders to securely access large-scale
pharmacy datasets. These systems promote real-time data availability, enabling
researchers and industry players to track emerging prescription trends, monitor
therapeutic adoption rates, and detect early signs of potential health crises.
Strategic alliances between pharmacies, academic institutions, and analytics
firms are accelerating the application of predictive modeling in areas such as
drug safety monitoring and chronic disease management. Enhanced use of
blockchain technology is also emerging, ensuring secure, tamper-proof data
transactions while maintaining regulatory compliance. The rise in consumer-driven
healthcare models is further encouraging the use of aggregated pharmacy data to
understand behavior patterns and align service delivery with evolving patient
preferences.
Significant
growth opportunities lie in expanding the application of de-identified pharmacy
datasets into emerging healthcare areas such as pharmacogenomics, real-world
evidence generation, and predictive health risk modeling. The increasing
adoption of wearable devices and mobile health applications opens pathways for
combining pharmacy transaction data with lifestyle and biometric data, creating
richer datasets for precision healthcare initiatives. Retail pharmacies can
also monetize insights to support payers in designing risk-adjusted insurance
models or aid policymakers in shaping targeted health interventions. With
growing demand from life sciences companies for real-world data in post-market
drug surveillance and therapy optimization, retail pharmacies stand to become
critical partners in the next phase of data-driven healthcare innovation in the
United States.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States Retail Pharmacy De-identified Health Data Market”
The United
States Retail Pharmacy De-identified Health Data Market is segmented into dataset
type, regional distribution, and company.
Based on the Dataset
Type, Episodic Data/Pharmacy Rx Claims Data emerged as the fastest growing
segment in the United States Retail Pharmacy De-identified Health Data Market during
the forecast period. This is driven
by the rich, detailed insights this data provides regarding patient medication
histories, prescription fill patterns, and treatment adherence. Pharmacy Rx
Claims Data enables healthcare providers, pharmaceutical companies, and payers
to analyze real-world medication usage and outcomes, supporting more informed
decision-making in clinical care and drug development. The increasing
digitization of pharmacy claims processes, coupled with the widespread adoption
of electronic health records and pharmacy management systems, has significantly
expanded the volume and quality of episodic data available for analysis. Moreover,
the growing emphasis on value-based care and outcomes-driven reimbursement
models relies heavily on this data to assess treatment effectiveness and
optimize healthcare spending.
Based
on the Region, West emerged as the fastest growing region in the United
States Retail Pharmacy De-identified Health Data Market during the forecast period. This is driven
by a combination of technological advancement and increasing healthcare
digitization. States in this region, such as California, Washington, and
Oregon, have been at the forefront of adopting advanced data analytics
platforms, cloud-based storage solutions, and artificial intelligence for
healthcare applications. Strong collaborations between retail pharmacy chains,
health tech startups, and research institutions have facilitated the
development of more comprehensive and actionable de-identified health datasets.
This has enhanced the value proposition of retail pharmacies as key
stakeholders in healthcare data ecosystems. The region’s growing emphasis on
preventive healthcare and personalized medicine is fueling demand for
high-quality, de-identified datasets that can be leveraged for predictive
analytics, population health management, and targeted intervention strategies.
Major
companies operating in United States Retail Pharmacy De-identified Health Data
Market are:
- CVS
Health Corporation
- Walgreens
Boots Alliance, Inc.
- Walmart
Inc.
- The
Kroger Co.
- Albertsons
Companies, Inc.
- UnitedHealth
Group Incorporated
- Humana
Inc.
- BrightSpring
Health Services, Inc.
- Costco
Wholesale Corporation
- Centene
Corporation
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The United States Retail Pharmacy
De-identified Health Data Market is expanding due to the rising adoption of
interoperable health data exchange platforms by retail pharmacies, which is
transforming the way pharmacy-generated data is utilized across the healthcare
ecosystem. Interoperability enables seamless integration of prescription
records, medication adherence information, and other pharmacy-related datasets
with electronic health records (EHRs) and clinical decision support systems
(CDSS). This interconnected approach allows healthcare providers to access a
more complete patient profile, improving diagnosis accuracy, treatment
personalization, and care coordination between physicians, pharmacists, and
other stakeholders. These factors are expected to drive the market's expansion
throughout the forecast period.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“United States Retail
Pharmacy De-identified Health Data Market By Dataset Type [DSCSA Data {By Buyer
Type (Pharmaceutical Manufacturers, Drug Distributors, Regulatory Tech Vendors,
Healthcare SaaS Vendors, Others)}; Market Basket Data {By Buyer Type (CPG &
Pharma Brands, Marketing & AdTech Firms, Health Insurers & PBMs, Retail
Analytics Platforms, Others)}; Prior Authorization Data {By Buyer Type (Payers
& PBMs, Pharma Market Access Teams, Health IT Providers, Consulting &
Policy Firms, Others)}; Inventory Data {By Buyer Type (Pharma Manufacturers,
Distributors/Wholesalers, AI/ML Inventory Optimization Vendors, Others)};
Episodic Data/Pharmacy Rx Claims Data {By Buyer Type (Value-based Payers &
ACOs, Pharma Outcomes Teams, Real-world Evidence Vendors, CMS & Government
Organizations, Others)}], By Region and Competition, Forecast &
Opportunities, 2020-2030F”, has evaluated the future growth potential of United
States Retail Pharmacy De-identified Health Data Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in United States Retail Pharmacy De-identified Health Data Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com